Watch Ticker

Oragenics Inc.

Go to Oragenics Inc. Website

$1.26

0.00 (0.00%)

Live

Previous Close

$1.26

Day Range

$1.25 - $1.34

Previous Day Range

$1.25 - $1.28

Market Cap

$1.0 million USD

Day Vol.

99082

Previous Day Vol.

75583

Currency

USD

Primary Exchange

NYSE American, LLC

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophil...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial

Oragenics, Inc. has submitted a clinical trial protocol for regulatory review to the Health and Disability Ethics Committee in New Zealand for its Phase II trial evaluating ONP-002, a proprietary neurosteroid therapy, for the treatment of mild traumatic brain injury or concussion.

Related tickers: OGEN.

Read Full Article

Oragenics, Inc. - Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards

Oragenics provides an update on its drug candidate ONP-002 for treating concussion, including positive developments in stability, formulation, and clinical trial preparation. However, the company also discloses non-compliance with NYSE American listing standards.

Related tickers: OGEN.

Read Full Article

Trending Tickers

Please sign in to view